InvestorsHub Logo
Followers 9
Posts 157
Boards Moderated 0
Alias Born 01/31/2014

Re: mightymoe post# 487

Tuesday, 09/08/2015 11:31:05 PM

Tuesday, September 08, 2015 11:31:05 PM

Post# of 1350
Hi mighty, I just read the Bloomberg link and their description, there's been an update since then, not sure if you knew, Carnell wants Perseon to focus only on the MicroThermX system now.

“Since joining BSD in November, I have made some initial observations based on extensive meetings with customers, employees, and physicians that have informed our strategic plan for the next several years,” said Clint Carnell, CEO of BSD Medical. “What’s clear to me is that BSD is an established leader in groundbreaking medical systems to treat cancer with heat therapy, and the MicroThermX® system is the leading microwave ablation technology. However, the Company’s dual focus on hyperthermia and microwave ablation since 2010 has diluted our ability to effectively market, sell, and invest in the commercial success of both businesses. Success in Life Sciences requires an evidence-based approach coupled with top line sales growth through customer adoption – and in order for BSD to be successful, we need to focus on microwave ablation. In 2015, we intend to focus on successfully exiting our hyperthermia business, and implementing a strategic plan that is exclusively focused on our highest return opportunity – the disruptive, high-growth microwave ablation market."

Link to PR that has the above: http://investor.perseonmedical.com/phoenix.zhtml?c=75162&p=irol-newsArticle&ID=2057294

I need to look at the last CC transcripts (cc from 8/7), but i think i remember him saying during the call that they are now totally free of the hyperthermia business, and it's all about MicroThermX now.



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.